These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 39219277)

  • 1. TREM2, a critical activator of pyroptosis, mediates the anti‑tumor effects of piceatannol in uveal melanoma cells via caspase 3/GSDME pathway.
    Jiu X; Li W; Liu Y; Liu L; Lu H
    Int J Mol Med; 2024 Nov; 54(5):. PubMed ID: 39219277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural withanolide withaferin A induces apoptosis in uveal melanoma cells by suppression of Akt and c-MET activation.
    Samadi AK; Cohen SM; Mukerji R; Chaguturu V; Zhang X; Timmermann BN; Cohen MS; Person EA
    Tumour Biol; 2012 Aug; 33(4):1179-89. PubMed ID: 22477711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erdafitinib promotes ferroptosis in human uveal melanoma by inducing ferritinophagy and lysosome biogenesis via modulating the FGFR1/mTORC1/TFEB signaling axis.
    Zhu X; Wang L; Wang K; Yao Y; Zhou F
    Free Radic Biol Med; 2024 Sep; 222():552-568. PubMed ID: 38971541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo anti-uveal melanoma activity of JSL-1, a novel HDAC inhibitor.
    Wang Y; Liu M; Jin Y; Jiang S; Pan J
    Cancer Lett; 2017 Aug; 400():47-60. PubMed ID: 28455241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pristimerin-induced uveal melanoma cell death via inhibiting PI3K/Akt/FoxO3a signalling pathway.
    Yan F; Liao R; Silva M; Li S; Jiang Y; Peng T; Lazarovici P; Zheng W
    J Cell Mol Med; 2020 Jun; 24(11):6208-6219. PubMed ID: 32347651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of inhibition of hedgehog signaling on cell growth and migration of uveal melanoma cells.
    Duan F; Lin M; Li C; Ding X; Qian G; Zhang H; Ge S; Fan X; Li J
    Cancer Biol Ther; 2014 May; 15(5):544-59. PubMed ID: 24553082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis.
    Zhou B; Zhang JY; Liu XS; Chen HZ; Ai YL; Cheng K; Sun RY; Zhou D; Han J; Wu Q
    Cell Res; 2018 Dec; 28(12):1171-1185. PubMed ID: 30287942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma
    Zhou J; Jin B; Jin Y; Liu Y; Pan J
    Theranostics; 2017; 7(6):1447-1462. PubMed ID: 28529629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neddylation Blockade Diminishes Hepatic Metastasis by Dampening Cancer Stem-Like Cells and Angiogenesis in Uveal Melanoma.
    Jin Y; Zhang P; Wang Y; Jin B; Zhou J; Zhang J; Pan J
    Clin Cancer Res; 2018 Aug; 24(15):3741-3754. PubMed ID: 29233905
    [No Abstract]   [Full Text] [Related]  

  • 10. Local anesthetic tetracaine hydrochloride induces pyroptosis via caspase-3/gasdermin E in uveal melanoma.
    Yi P; Zhang R; Qin Z; Zhao X; Wu C; Yu Y; Liu L; Zhou J; Feng J
    Biomed Pharmacother; 2024 Nov; 180():117471. PubMed ID: 39321515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salinomycin effectively eliminates cancer stem-like cells and obviates hepatic metastasis in uveal melanoma.
    Zhou J; Liu S; Wang Y; Dai W; Zou H; Wang S; Zhang J; Pan J
    Mol Cancer; 2019 Nov; 18(1):159. PubMed ID: 31718679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The multi-kinase inhibitor afatinib serves as a novel candidate for the treatment of human uveal melanoma.
    Shu W; Zhu X; Wang K; Cherepanoff S; Conway RM; Madigan MC; Zhu H; Zhu L; Murray M; Zhou F
    Cell Oncol (Dordr); 2022 Aug; 45(4):601-619. PubMed ID: 35781872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting primary and metastatic uveal melanoma with a G protein inhibitor.
    Onken MD; Makepeace CM; Kaltenbronn KM; Choi J; Hernandez-Aya L; Weilbaecher KN; Piggott KD; Rao PK; Yuede CM; Dixon AJ; Osei-Owusu P; Cooper JA; Blumer KJ
    J Biol Chem; 2021; 296():100403. PubMed ID: 33577798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental therapy of doxorubicin resistant human uveal melanoma with targeted cytotoxic luteinizing hormone-releasing hormone analog (AN-152).
    Oláh G; Dobos N; Vámosi G; Szabó Z; Sipos É; Fodor K; Harda K; Schally AV; Halmos G
    Eur J Pharm Sci; 2018 Oct; 123():371-376. PubMed ID: 30076951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pristimerin effectively inhibits the malignant phenotypes of uveal melanoma cells by targeting NF‑κB pathway.
    Zhang B; Zhang J; Pan J
    Int J Oncol; 2017 Sep; 51(3):887-898. PubMed ID: 28766683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol inhibits uveal melanoma tumor growth via early mitochondrial dysfunction.
    van Ginkel PR; Darjatmoko SR; Sareen D; Subramanian L; Bhattacharya S; Lindstrom MJ; Albert DM; Polans AS
    Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1299-306. PubMed ID: 18385041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pristimerin attenuates cell proliferation of uveal melanoma cells by inhibiting insulin-like growth factor-1 receptor and its downstream pathways.
    Xie X; Xie S; Xie C; Fang Y; Li Z; Wang R; Jiang W
    J Cell Mol Med; 2019 Nov; 23(11):7545-7553. PubMed ID: 31508890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidating the role of the FoxO3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells.
    Yan F; Liao R; Farhan M; Wang T; Chen J; Wang Z; Little PJ; Zheng W
    Biomed Pharmacother; 2016 Dec; 84():1538-1550. PubMed ID: 27881235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Anti-malarial Drug Artesunate Blocks Wnt/β-catenin Pathway and Inhibits Growth, Migration and Invasion of Uveal Melanoma Cells.
    Zheng L; Pan J
    Curr Cancer Drug Targets; 2018; 18(10):988-998. PubMed ID: 29692251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Verification of EZH2 as a druggable target in metastatic uveal melanoma.
    Jin B; Zhang P; Zou H; Ye H; Wang Y; Zhang J; Yang H; Pan J
    Mol Cancer; 2020 Mar; 19(1):52. PubMed ID: 32127003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.